Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Goodwill (2019 - 2025)

Cresco Labs (CRLBF) has disclosed Goodwill for 3 consecutive years, with $330.6 million as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Goodwill fell 26.01% year-over-year to $330.6 million, compared with a TTM value of $330.6 million through Dec 2022, down 26.01%, and an annual FY2022 reading of $330.6 million, down 26.01% over the prior year.
  • Goodwill was $330.6 million for Q4 2022 at Cresco Labs, down from $446.8 million in the prior quarter.
  • Across five years, Goodwill topped out at $446.8 million in Q4 2021 and bottomed at $137.7 million in Q4 2019.
  • Average Goodwill over 3 years is $305.0 million, with a median of $330.6 million recorded in 2022.
  • Peak annual rise in Goodwill hit 26.01% in 2022, while the deepest fall reached 26.01% in 2022.
  • Year by year, Goodwill stood at $137.7 million in 2019, then skyrocketed by 224.4% to $446.8 million in 2021, then decreased by 26.01% to $330.6 million in 2022.
  • Business Quant data shows Goodwill for CRLBF at $330.6 million in Q4 2022, $446.8 million in Q4 2021, and $137.7 million in Q4 2019.